Holdings
Vanguard Health Care Index Fund
As of May 31, 2026, Vanguard Health Care Index Fund reported 396 positions worth US$19B. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 2.41M | US$2.67B | −2,942 | May 31, 2026 |
| Johnson & Johnson | 7.14M | US$1.61B | +1,833 | May 31, 2026 |
| Abbvie Inc. | 5.31M | US$1.16B | +1,842 | May 31, 2026 |
| Unitedhealth Group Incorporated | 2.72M | US$1.03B | +349 | May 31, 2026 |
| Merck & Company, Inc. | 7.45M | US$885M | −47,873 | May 31, 2026 |
| Thermo Fisher Scientific Inc | 1.13M | US$556M | −5,846 | May 31, 2026 |
| Amgen Inc. | 1.62M | US$545M | +149 | May 31, 2026 |
| Gilead Sciences, Inc. | 3.73M | US$501M | −731 | May 31, 2026 |
| Intuitive Surgical, Inc. | 1.06M | US$452M | −12,100 | May 31, 2026 |
| Pfizer, Inc. | 17.1M | US$447M | −1,548 | May 31, 2026 |